REPLIGEN/NNP Inc./NNP said/VBD it/PRP will/MD issue/VB one/CD million/CD new/JJ common/JJ shares/NNS in/IN a/DT $/$ 9/CD million/CD private/JJ placement/NN to/TO institutional/JJ investors/NNS in/IN the/DT U.K/NNP ./.
The/DT Cambridge/NNP ,/, Mass./NNP ,/, biotechnology/NN company/NN said/VBD proceeds/NNS will/MD be/VB used/VBN to/TO broaden/VB its/PRP$ research/NN and/CC development/NN of/IN products/NNS to/TO fight/VB infectious/JJ diseases/NNS and/CC to/TO increase/VB manufacturing/NN capabilities/NNS ./.
Bear/NNP Stearns/NNP &/CC Co./NNP handled/VBD the/DT closing/NN of/IN the/DT transactions/NNS ,/, Repligen/NNP ./.
the/DT sale/NN ,/, Repligen/NNP will/MD have/VB about/IN 8.3/CD million/CD shares/NNS ./.
